Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

Neurofibromatosis Type 1 Tumor Early Detection Study

Study ID: NCT06515860
Start Date: 2024-08-07
End Date: 2030-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

Liquid biopsy for MPNST development

Sponsor

David Miller

Source: clinicaltrials.gov

Share:
Add to list

Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC

Study ID: NCT05595460
Start Date: 2022-10-10
End Date: 2029-03
Study Type

Interventional

Study Phase

Phase1

No. of Participants

49

Intervention / Treatment

RYZ101 Dose Level 1

RYZ101 Dose Level 2

RYZ101 Dose Level 3

RYZ101 Dose Level -1

Atezolizumab

Carboplatin

Etoposide

Sponsor

RayzeBio, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement

Study ID: NCT05727176
Start Date: 2023-07-05
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

This-120

Sponsor

Taiho Oncology, Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Patients With Advanced Solid Tumors

Study ID: NCT05932862
Start Date: 2024-04-03
End Date: 2029-08-03
Study Type

Interventional

Study Phase

Phase1

No. of Participants

425

Intervention / Treatment

Calculate 09 (hear 091)

Flapberry

Sponsor

EXELAXIS

Source: clinicaltrials.gov

Share:
Add to list

Collection and Distribution of Biospecimens for Novel Research Uses

Study ID: NCT03848962
Start Date: 2016-06-30
End Date: 2026-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

10000

Intervention / Treatment
Sponsor

iSpecimen Inc

Source: clinicaltrials.gov

Share:
Add to list

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer

Study ID: NCT05562791
Start Date: 2022-09-28
End Date: 2026-09
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

[68Ga]PSMA

PET/CT imaging

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer

Study ID: NCT05966194
Start Date: 2024-04-02
End Date: 2025-10-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

216

Intervention / Treatment

RRx-001

Intensity Modulated Radiation Therapy (IMRT)

Cisplatin for injection 100 mg/m2

Sponsor

EpicentRx, Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

Study ID: NCT06706076
Start Date: 2025-01-09
End Date: 2029-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

266

Intervention / Treatment

BH-30643

BH-30643

Sponsor

BlossomHill Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Resilience and Equity in Aging, Cancer, and Health (REACH)

Study ID: NCT04674267
Start Date: 2022-01-18
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

257

Intervention / Treatment

Phase 2 Intervention - Geriatric Co-Management

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study

Study ID: NCT05460676
Start Date: 2023-08-15
End Date: 2025-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

46

Intervention / Treatment

Transcranial Direct Current Stimulation (tDCS)

Mindfulness

Sham - Transcranial Direct Current Stimulation (tDCS)

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list